⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

March 13, 2024Current OncologyOpen Access

The Influence of Additional Treatments on the Survival of Patients Undergoing Transarterial Radioembolization (TARE)

View Full Paper

Ask AI

Bookmark

Share

Authors

NQNatale QuartuccioOspedale Vincenzo Cervello SISalvatore IalunaOspedale Vincenzo Cervello DSDaniele ScalisiOspedale Vincenzo Cervello

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Quartuccio et al. (2024) studied this question.

synapsesocial.com/papers/68e74453b6db6435876bd4a2 https://doi.org/10.3390/curroncol31030114

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

1PET/CT with 18F-choline or 18F-FDG in Hepatocellular Carcinoma Submitted to 90Y-TARE: A Real-World Study2022 · 12 citations
2Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma2011 · 309 citations
3Relationship of Tumor Radiation–absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with 90 Y in the SARAH Study2020 · 208 citations